Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.

Ludwig N, Keller A, Heisel S, Leidinger P, Rheinheimer S, Andres C, Stephan B, Steudel WI, Donauer E, Graf N, Burgeth B, Weickert J, Lenhof HP, Meese E.

Int J Cancer. 2011 Mar 15;128(6):1493-501. doi: 10.1002/ijc.25467.

2.

Improving seroreactivity-based detection of glioma.

Ludwig N, Keller A, Heisel S, Leidinger P, Klein V, Rheinheimer S, Andres CU, Stephan B, Steudel WI, Graf NM, Burgeth B, Weickert J, Lenhof HP, Meese E.

Neoplasia. 2009 Dec;11(12):1383-9.

3.

MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.

Comtesse N, Niedermayer I, Glass B, Heckel D, Maldener E, Nastainczyk W, Feiden W, Meese E.

Oncogene. 2002 Jan 10;21(2):239-47.

4.

Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.

Doroudchi M, Pishe ZG, Malekzadeh M, Golmoghaddam H, Taghipour M, Ghaderi A.

Asian Pac J Cancer Prev. 2013;14(9):5225-30.

5.

Five novel immunogenic antigens in meningioma: cloning, expression analysis, and chromosomal mapping.

Comtesse N, Heckel D, Rácz A, Brass N, Glass B, Meese E.

Clin Cancer Res. 1999 Nov;5(11):3560-8.

6.

Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.

Comtesse N, Zippel A, Walle S, Monz D, Backes C, Fischer U, Mayer J, Ludwig N, Hildebrandt A, Keller A, Steudel WI, Lenhof HP, Meese E.

Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9601-6. Epub 2005 Jun 27.

7.

Case-control study of neuroepithelial tumors in Rochester, Minnesota, 1950-1977.

Codd MB, Kurland LT, O'Fallon WM, Beard CM, Cascino TL.

Neuroepidemiology. 1990;9(1):17-26.

PMID:
2330067
8.

A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors.

Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, Lenhof HP.

BMC Bioinformatics. 2006 Dec 21;7:539.

9.

Secretion and immunogenicity of the meningioma-associated antigen TXNDC16.

Harz C, Ludwig N, Lang S, Werner TV, Galata V, Backes C, Schmitt K, Nickels R, Krause E, Jung M, Rettig J, Keller A, Menger M, Zimmermann R, Meese E.

J Immunol. 2014 Sep 15;193(6):3146-54. doi: 10.4049/jimmunol.1303098. Epub 2014 Aug 13.

10.

Tumor-associated autoantibody signature for the early detection of gastric cancer.

Zayakin P, Ancāns G, Siliņa K, Meistere I, Kalniņa Z, Andrejeva D, Endzeliņš E, Ivanova L, Pismennaja A, Ruskule A, Doniņa S, Wex T, Malfertheiner P, Leja M, Linē A.

Int J Cancer. 2013 Jan 1;132(1):137-47. doi: 10.1002/ijc.27667. Epub 2012 Jul 3.

11.

Autologous antibodies to meningioma cell surface antigens.

Pfreundschuh M, Röhrich M, Piotrowksi W, Penzholz H, Fischer H.

Anticancer Res. 1981;1(6):367-72.

PMID:
6284017
12.

Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.

Ummanni R, Duscharla D, Barett C, Venz S, Schlomm T, Heinzer H, Walther R, Bokemeyer C, Brümmendorf TH, Murthy PV, Balabanov S.

J Proteomics. 2015 Apr 24;119:218-29. doi: 10.1016/j.jprot.2015.02.005. Epub 2015 Feb 24.

PMID:
25724726
13.

Novel tankyrase-related gene detected with meningioma-specific sera.

Monz D, Munnia A, Comtesse N, Fischer U, Steudel WI, Feiden W, Glass B, Meese EU.

Clin Cancer Res. 2001 Jan;7(1):113-9.

14.

Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.

Mottet S, Martin-Achard A, de Tribolet N, Diserens AC.

Acta Neurochir (Wien). 1980;52(1-2):19-25.

PMID:
7376941
15.

Risk of meningioma and common variation in genes related to innate immunity.

Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M, Thomas G, Fine HA, Linet MS, Rothman N, Chanock SJ, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1356-61. doi: 10.1158/1055-9965.EPI-09-1151. Epub 2010 Apr 20.

16.

Combining gene expression signatures and autoantibody profiles in human meningioma.

Keller A, Ludwig N, Comtesse N, Henn W, Steudel WI, Lenhof HP, Meese E.

Gene Ther. 2009 Feb;16(2):184-9. doi: 10.1038/gt.2008.130. Epub 2008 Aug 14.

PMID:
18701916
17.

Serological analysis of tumor antigens in malignant glioma patients.

Yoshida S, Tanaka R, Ono K.

Neurol Med Chir (Tokyo). 1991 Sep;31(9):559-62.

18.

NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.

Baia GS, Caballero OL, Ho JS, Zhao Q, Cohen T, Binder ZA, Salmasi V, Gallia GL, Quinones-Hinojosa A, Olivi A, Brem H, Burger P, Strausberg RL, Simpson AJ, Eberhart CG, Riggins GJ.

Cancer Immunol Res. 2013 Nov;1(5):296-302. doi: 10.1158/2326-6066.CIR-13-0029. Epub 2013 Aug 5.

19.

Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.

Zhou SL, Ku JW, Fan ZM, Yue WB, Du F, Zhou YF, Liu YL, Li Y, Tang S, Hu YL, Hu XP, Hou ZC, Liu J, Liu Y, Feng XS, Wang LD.

Dis Esophagus. 2015 May-Jun;28(4):371-9. doi: 10.1111/dote.12206. Epub 2014 Mar 10.

PMID:
24612004
20.

Meningioma: is there an association with human leukocyte antigens?

Machulla HK, Steinborn F, Tschigrjai M, Langner J, Rainov NG.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1438-42.

Items per page

Supplemental Content

Write to the Help Desk